Streptokinase and urokinase: minimizing the risks of these thrombolytics.
作者信息
Gever L N
出版信息
Nursing. 1983 Jan;13(1):76. doi: 10.1097/00152193-198301000-00023.
Abstract
摘要
相似文献
1
Streptokinase and urokinase: minimizing the risks of these thrombolytics.链激酶和尿激酶：降低这些溶栓药物的风险
Nursing. 1983 Jan;13(1):76. doi: 10.1097/00152193-198301000-00023.
2
Thrombolytic therapy: differences between streptokinase and urokinase.溶栓治疗：链激酶与尿激酶的差异
Vasc Surg. 1977 Nov-Dec;11(6):378-83. doi: 10.1177/153857447701100607.
3
[New technics in the treatment of the coronary insufficiency. Conclusions].[冠状动脉供血不足治疗中的新技术。结论]
G Ital Cardiol. 1983;13(4):357-9.
4
[Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].[溶栓剂与急性肺栓塞。28例接受链激酶或尿激酶-肝素治疗的研究]
Coeur Med Interne. 1978 Jan-Mar;17(1):59-66.
5
Thrombolytic therapy: Current status.溶栓治疗：现状
N Engl J Med. 1975 Nov 20;293(21):1073-8. doi: 10.1056/NEJM197511202932106.
6
Oral administration of urokinase.口服尿激酶。
Thromb Res. 1980;20(5-6):711-4. doi: 10.1016/0049-3848(80)90161-9.
7
Current concepts: guidelines for the use of thrombolytic agents.当前概念：溶栓药物使用指南
N Engl J Med. 1979 Dec 6;301(23):1266-70. doi: 10.1056/NEJM197912063012305.
8
[When is fibrinolytic therapy indicated?].[何时适合进行纤溶治疗？]
Med Klin. 1980 Feb 1;75(3):98-107.
9
Intra-arterial fibrinolytic therapy. Efficacy of streptokinase vs urokinase.动脉内溶栓治疗。链激酶与尿激酶的疗效比较。
Arch Surg. 1986 Jul;121(7):769-73. doi: 10.1001/archsurg.1986.01400070035007.
10
[Fibrinolytic therapy of deep venous thrombosis. Streptokinase, urokinase, plasminogen substitution].[深静脉血栓形成的纤维蛋白溶解疗法。链激酶、尿激酶、纤维蛋白原替代疗法]
Dtsch Med Wochenschr. 1980 Feb 22;105(8):243-6. doi: 10.1055/s-2008-1070642.
Zotero 插件